STRIDES PHARMA SCI
STAR.NS
₹ 784.70
1%

Strides Pharma Science Ltd

Strides Pharma Science Ltd is a Small Cap stock that belongs to the Pharmaceuticals & Drugs sector. The current live share price of Strides Pharma is ₹ 784.70 that is ₹ 9.60 1.24% with respect to the previous day’s close price. The stock price of Strides Pharma was last updated 14 hours ago.

Strides Pharma Stock Price Performance

In the below section, we have evaluated the stock’s price performance for the last traded day as well as historical time frames.

Strides Pharma Live Share Price Analysis

STRIDES PHARMA SCI
₹ 784.70
Open ₹ 779.95
High ₹ 793.00
Marketcap 72.11B
Close ₹ 784.70
Low ₹ 776.60
Volume ₹ 181,288.00

The stock of Strides Pharma Science Ltd strated the trade at an Open price of ₹ 779.95 when the trading at exchange began for the day. It touched an Intraday High price of ₹ 793.00 and an Intraday Low price of ₹ 776.60%. As per last updated 14 hours ago, the Shares of Strides Pharma were trading at a price of ₹ 784.70 which is ₹ 9.60 1.24% as compared the price ₹ 775.10 at which the stock close on the previous trading day. The total traded volume for the day stood at 181,288 number of shares.

Candlestick Chart of Strides Pharma Share Price Movements

The following candlestick Chart of the Stock shows how the Open, High, Low, Close (OHLC) Price of the share has performed in the last month (30-day period).

Historical Performance of Strides Pharma Shares

52 Week RangePrice52 Weeks Low52 Weeks High
₹ 784.70₹ 285.00₹ 838.60

Here is Strides Pharma’s price performance analysis over the last year. The stock has seen the 52 weeks high price level of ₹ 838.60. On the lower side, the stock has been to the 52 weeks low price level of ₹ 285.00. It’s last traded price was ₹ 784.70 as on last update 14 hours ago. The one-year line chart clearly shows how the price of Strides Pharma’s stock has moved in the last twelve months.

The Company has posted an earnings of ₹ -16.82 per share (EPS TTM) in the trailing twelve months period. Strides Pharma’s last annual dividend rate was 1.5%, which translates to a 0.19% of annual dividend yield.

Line Chart of Strides Pharma Stock Price

Here is the chart of stock price performance for the last one year. You can also view the price performance of a different period by selecting the time frame from the top right corner.

Companies Similar to Strides Pharma

Strides Pharma Science Ltd belongs to the Pharmaceuticals & Drugs sector. It has several competitors in the same industry. The snapshot of the live share price of some of the companies similar to Strides Pharma are listed below. You can click and view the details of stock analysis, current and historical share price, company background information about each company.

Share Price Snapshot Companies Similar to Strides Pharma

Select list of companies is given below. To view more about the Industry and see other companies from Industry, click on the industry name.
ALEMBICLTD.NSALEMBIC LTD
₹ 83.45
NSE
₹ 3.10
3.86%

About Strides Pharma

Strides Pharma Science Ltd is a Private Company. The company operates in the Pharmaceuticals & Drugs sector. Strides Pharma Science Ltd, formerly Strides Shasun Limited, is a vertically integrated global pharmaceutical company. Incorporated in 1990, it has around 31 years of operations. Strides Pharma live share price is ₹ 784.70. It is a Small Cap stock and had a market capitalization of ₹ 72,113,692,672.00 as on 14 hours ago.

  • Strides Pharma is engaged in the development and manufacturing of active pharmaceutical ingredients (APIs) and formulations, as well as biotech.
  • Its business segments include Pharmaceutical and Biotech businesses.
  • Its geographical segments are Africa, Australasia, North America and Europe, South and Central America, India and Others.
  • The Company focuses on developing complex pharmaceutical products across therapeutic segments.
  • The Company’s products include general tablets, hard gelatin capsules, soft gelatin capsules, sachets, dry powders, dry syrups, potent drugs, semi solids, ointments and creams.
  • It is also involved in supplying generics to hospitals approved by the National Health Service (NHS) and over-the-counter (OTC) products through retail outlets.
  • It operates approximately 10 facilities, which are diversified across Asia, Africa and Europe.

The registered office of Strides Pharma is located in Navi Mumbai, Maharashtra. The registrar and share transfer agent for Strides Pharma is K FIN Technologies Pvt Ltd. The Stock Exchanges on which shares of Strides Pharma Science Ltd is listed includes BSE, NSE, MCX.

STRIDES PHARMA SCI
Status: Active
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 2850
Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company has a strategic partnership with Orbicular Pharmaceutical Technologies Private Limited to develop, manufacture, and commercialize nasal sprays. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.
AddressStrides House, Bengaluru, India
CountryIndia
Phone91 80 6784 0000
Websitehttps://www.strides.com

Strides Pharma Recent News

No Recent News found for Strides Pharma Science Ltd.